← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2007Last known activity
Nov 14, 2022
Timeline
2000s
- Jun 1, 2006
Tracon Pharmaceuticals Inc.— Founded
Drugs by trial phase (17 distinct, 22 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Choriocarcinoma
- Gestational Trophoblastic Disease
- Glioblastoma
- Hemangiosarcoma
- Histiocytoma, Malignant Fibrous
- Lung Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Prostatic Neoplasms
- Sarcoma
- Trophoblastic Neoplasms
- Trophoblastic Tumor, Placental Site
Recent trials (32)
- NCT05448820Lead sponsorPhase 1/Phase 2Nov 14, 2022
- NCT04480502Study directorPhase 2Dec 31, 2020
- NCT04480502Lead sponsorPhase 2Dec 31, 2020
- NCT03835949Lead sponsorPhase 1Apr 12, 2019
- NCT03181308Lead sponsorPhase 1Jul 1, 2017
- NCT02987829Lead sponsorPhase 1/Phase 2Apr 1, 2017
- NCT02987829Study directorPhase 1/Phase 2Apr 1, 2017
- NCT02979899Study directorPhase 3Feb 13, 2017
- NCT02979899Lead sponsorPhase 3Feb 13, 2017
- NCT02664961Lead sponsorPhase 2Mar 1, 2016
- NCT02664961Study directorPhase 2Mar 1, 2016
- NCT02520063CollaboratorPhase 1/Phase 2Feb 1, 2016
- NCT02560779Lead sponsorPhase 1/Phase 2Jan 1, 2016
- NCT02560779Study directorPhase 1/Phase 2Jan 1, 2016
- NCT02429843CollaboratorPhase 1Jan 1, 2016
Details
- Founded
- San Diego, CA, US Jun 1, 2006
- Last known activity
- Nov 14, 2022